Sort
130,381 grants matching “hiv”
Anti-viral immune responses in lymph node
$2,327,720Ulrich H Von Andrian · Harvard Medical School · P01 · FY2008 · AI
A defend and destroy approach to curing HIV
$2,327,582David T Scadden · Harvard University · U19 · FY2015 · HL
UNIVERSIDAD CENTRAL DEL CARIBE BIOMEDICAL RESEARCH CENTERS
$2,325,727Jose Ginel Rodriguez · Universidad Central Del Caribe · G12 · FY2013 · MD
HIV/AIDS Vaccine and Antibody Development
$2,325,099Cheng Cheng · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
HIV/AIDS Vaccine and Antibody Development
$2,325,099Cheng Cheng · National Institute Of Allergy And Infectious Diseases · ZIC · FY2022 · AI
HIV/AIDS Vaccine and Antibody Development
$2,325,099Cheng Cheng · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Preventing HIV by modifying the context for injecting initiation
$2,325,000Daniel M Werb · University Of California, San Diego · DP2 · FY2015 · DA
IMPROVING THE DELIVERY & MANAGEMENT OF HIV /AIDS CARE IN MALAWI THROUGH APPROPRIA
$2,325,000Sabine Joukes · Baobab Health Trust · U2G · FY2010 · PS
Pont-of-use Acute HIV Infection Diagnostic for Substance Using Populations
$2,325,000Jacqueline Linnes · Purdue University · DP2 · FY2020 · DA
MBRS-SCORE PROGRAM AT UPR, MEDICAL SCIENCES CAMPUS
$2,322,206University Of Puerto Rico Med Sciences · S06 · FY2002 · GM
UCLA Los Angeles Brazil AIDS Consortium
$2,322,195Yvonne J Bryson · University Of California Los Angeles · U01 · FY2007 · AI
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
$2,321,982Louis J. Picker · Oregon Health & Science University · U19 · FY2019 · AI
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
$2,321,982Louis J. Picker · Oregon Health & Science University · U19 · FY2020 · AI
Development of Immunogenicity- and Efficacy-Optimized CMV Vectors for an HIV/AIDS Vaccine
$2,321,981Louis J. Picker · Oregon Health & Science University · U19 · FY2021 · AI
NONHUMAN PRIMATE CORE HUMORAL IMMUNOLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT
$2,321,603David Montefiori · Duke University · N01 · FY2020 · AI
Protective Immunity
$2,321,479David I Watkins · University Of Miami School Of Medicine · P01 · FY2016 · AI
NIAID Preclinical Development Support
$2,321,304Nancy Lin · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
National Resource for Mass Spectrom of Biological Macromolecules
$2,320,963Brian T Chait · Rockefeller University · P41 · FY2013 · GM
Moon and Sun Brothers: A group-based Prevention Intervention
$2,320,682Emma V. Sanchez-Vaznaugh · San Francisco State University · UF1 · FY2025 · MH
Center/Coordination, Analysis and Management/MACS-Part B
$2,320,400Lisa P Jacobson · Johns Hopkins University · U01 · FY2008 · AI
Clinical Pharmacology Quality Assurance (CPQA)
$2,320,337Gene Morse · State University Of New York At Buffalo · N01 · FY2023 · AI
University of Puerto Rico Clinical Trials Unit
$2,320,253Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U01 · FY2008 · AI
Acute HIV Infection: Implications for vaccine design
$2,318,714Marcus Altfeld · Massachusetts General Hospital · P01 · FY2008 · AI
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$2,318,432Myron E Essex · Harvard School Of Public Health · U01 · FY2008 · AI
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORK
$2,318,298University Of Miami School Of Medicine · U10 · FY2004 · DA